Survival After Adjuvant Chemotherapy in Completely Resected N1 Non-Small Cell Lung Cancer

被引：0
|
作者：
Wang, E. [1 ]
Bourdages-Pageau, E. [1 ]
Gagnon, H. [1 ]
Labbe, C. [2 ]
Tremblay, L. [1 ]
Ugalde, P. [1 ]
机构：
[1] Inst Univ Cardiol & Pneumol Quebec, Thorac Oncol Surg, Quebec City, PQ, Canada
[2] Quebec Heart & Lung Inst Res Ctr, Quebec City, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
adjuvant chemotherapy; Non-Small Cell Lung Cancer;
D O I：
10.1016/j.jtho.2019.08.1333
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.18-17
引用
收藏
页码：S633 / S633
页数：1
相关论文
共 50 条
  • [31] The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer
    Almquist, Daniel R.
    Savvides, Panayiotis
    Ernani, Vinicius
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (03)
  • [32] The current status of adjuvant chemotherapy for resected non-small cell lung cancer
    Socinski, MA
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 27 - 33
  • [33] Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy
    Moon, Youngkyu
    Sung, Sook Whan
    Park, Jae Kil
    Lee, Kyo Young
    Ahn, Seha
    WORLD JOURNAL OF SURGERY, 2019, 43 (04) : 1162 - 1172
  • [34] Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy
    Youngkyu Moon
    Sook Whan Sung
    Jae Kil Park
    Kyo Young Lee
    Seha Ahn
    World Journal of Surgery, 2019, 43 : 1162 - 1172
  • [35] Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer
    Sun, J.
    Kim, H. K.
    Lee, S.
    Ahn, Y. C.
    Kim, J.
    Ahn, M.
    Zo, J. I.
    Shim, Y. M.
    Park, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2014 - S2014
  • [36] A prospective randomized study of adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Zheng Shi Ying
    Jiang Dong
    Li Hong
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S518 - S518
  • [37] Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall
    Drake, Justin A.
    Sullivan, Jennifer L.
    Weksler, Benny
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04): : 1794 - 1802
  • [38] RISK FACTORS FOR LOCOREGIONAL FAILURE IN COMPLETELY RESECTED N1 NON-SMALL CELL LUNG CANCER WITHOUT POSTOPERATIVE RADIOTHERAPY
    Cho, Sukki
    Park, Samina
    Jheon, Sanghoon
    Kim, Kwhanmien
    Yang, Hee Chul
    Yi, Eunjue
    Seok, Yangki
    Noh, Dongsub
    Yeom, Sung Won
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S813 - S814
  • [39] Adjuvant chemotherapy for completely resected non-small-cell lung cancer. Reply
    Keller, SM
    Johnson, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 690 - 690
  • [40] Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
    Lee, Kuan-Yu
    Hsu, Chen-Xiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 647 - 648
12345